Evanthia Roussos Torres, MD, PhD | Authors

Articles

Next Steps After Trial of Entinostat for Advanced Breast Cancer

December 06, 2021

Evanthia Roussos Torres, MD, PhD, discusses the follow-up research related to the phase 1 study of entinostat administered in combination with nivolumab and ipilimumab for the treatment of locally advanced, metastatic, unresectable, or HER2-negative breast cancer.

Triplet Therapy Shows Efficacy in Phase 1 Advanced Breast Cancer Trial

November 20, 2021

Evanthia Roussos Torres, MD, PhD, discusses the phase 1 study of the efficacy of entinostat administered in combination with nivolumab and ipilimumab for the treatment of locally advanced, metastatic, unresectable, or HER2-negative breast cancer.